Back to results
US 2024/0197735 A1Published application
Methods and compositions comprising a braf inhibitor and a pd-1 binding antagonist
AssigneeHoffmann-La Roche Inc.
InventorsJan ECKMANN, Thomas FRIESS, Frank HERTING, Piergiorgio Francesco Tommaso PETTAZZONI, Juergen WICHMANN
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the combination therapy of cancer with a BRAF inhibitor and a PD-1 axis binding anatgonist.
Claims19
A combination of a BRAF inhibitor and a PD-1 axis binding antagonist, wherein the BRAF inhibitor is a compound of formula (I):
- or a pharmaceutically acceptable salt or solvate thereof.
-9. (canceled)
(canceled)
Dependencies are inferred from the claim text.